Adicet Bio Inc.
Organization details
- Legal name
- Adicet Bio Inc.
- Former names
- resTORbio, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ACET
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001720580
- EIN
- 81-3305277
Board of directors
-
Andrew Sinclair · DirectorSince 2023
-
Aya Jakobovits · DirectorSince 2023
-
Bastiano Sanna · DirectorSince 2023
- Since 2023
-
Chen Schor · Director · President & CEOSince 2023
-
Erez Chimovits · DirectorSince 2023
-
Jeffrey Chodakewitz · DirectorSince 2023
-
Katie Peng · DirectorSince 2023
-
Lloyd Klickstein · Director · Chief Medical OfficerSince 2024
-
Michael Grissinger · DirectorSince 2025
-
Michael Kauffman · DirectorSince 2023
-
Steve Dubin · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.7%
-
86.4%
-
98.0%
Board connections
7 of this board's directors also sit on 19 other boards. 19 are in the same sector.
-
ADARx Pharmaceuticals Inc. Same sectorvia Carl L. Gordon and Erez Chimovits
-
Akari Therapeutics plc Same sectorvia Michael Grissinger
-
Aprea Therapeutics Inc. Same sectorvia Michael Grissinger
-
ArriVent BioPharma Inc. Same sectorvia Carl L. Gordon
-
BlossomHill Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Braveheart Bio Inc. Same sectorvia Erez Chimovits
-
Compass Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Electra Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Karyopharm Therapeutics Inc. Same sectorvia Chen Schor
-
Keros Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Kyntra Bio Inc. Same sectorvia Michael Kauffman
-
Lipocine Inc. Same sectorvia Michael Grissinger
-
MBX Biosciences Inc. Same sectorvia Carl L. Gordon
-
Praxis Precision Medicines Inc. Same sectorvia Jeffrey Chodakewitz
-
Scholar Rock Holding Corporation Same sectorvia Katie Peng
-
Schrodinger Inc. Same sectorvia Jeffrey Chodakewitz
-
Scribe Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Upstream Bio Inc. Same sectorvia Erez Chimovits
-
Verastem Inc. Same sectorvia Michael Kauffman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,603,934
- 3 purchases by 1 insider
- Sold, last 12 months
- $674,847
- 4 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 27, 2026 | Rajeev M. Shah 10% owner | Other | −250,000 | — | — |
| Apr 8, 2026 | OrbiMed Advisors Israel II Ltd 10% owner | Open-market sale | −32,523 | $6.29 | $204,570 |
| Apr 8, 2026 | OrbiMed Advisors Israel II Ltd 10% owner | Open-market sale | −40,416 | $6.52 | $263,512 |
| Apr 7, 2026 | OrbiMed Advisors Israel II Ltd 10% owner | Open-market sale | −29,319 | $6.53 | $191,453 |
| Apr 7, 2026 | OrbiMed Advisors Israel II Ltd 10% owner | Open-market sale | −2,400 | $6.38 | $15,312 |
| Feb 20, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +74,751 | $7.27 | $543,440 |
| Feb 19, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +74,268 | $7.21 | $535,472 |
| Feb 18, 2026 | RA Capital Healthcare Fund LP 10% owner | Open-market purchase | +74,577 | $7.04 | $525,022 |
| Jan 24, 2026 | Aftab Blake Officer (Chief Scientific Officer) | Shares withheld for tax | −535 | $8.44 | $4,515 |
| Jan 24, 2026 | Healey Don Officer (Chief Technology Officer) | Shares withheld for tax | −535 | $8.44 | $4,515 |
| Jan 24, 2026 | Chen Schor Director, Officer (President & CEO) | Shares withheld for tax | −1,755 | $8.44 | $14,812 |
| Jan 24, 2026 | Harvey Brian Nicholas Officer (Chief Financial Officer) | Shares withheld for tax | −546 | $8.44 | $4,608 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC 10% owner | Open-market purchase | +1,500,000 | $1.00 | $1,500,000 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC 10% owner | Open-market purchase | +3,500,000 | $1.00 | $3,500,000 |
| Jun 11, 2025 | Lloyd Klickstein Director | Grant or award | +5,900 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Adicet Bio Inc.
Who is the CEO of Adicet Bio Inc.?
Chen Schor is Adicet Bio Inc.'s President & CEO.
How many directors are on Adicet Bio Inc.'s board?
Adicet Bio Inc.'s board has 12 directors: Andrew Sinclair, Aya Jakobovits, Bastiano Sanna, Carl L. Gordon, Chen Schor, Erez Chimovits, Jeffrey Chodakewitz, Katie Peng, Lloyd Klickstein, Michael Grissinger and 2 others.
Are Adicet Bio Inc. insiders buying or selling shares?
Over the last 12 months, Adicet Bio Inc. insiders bought $1.6 million of shares in 3 purchases and sold $674,847 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="adicet-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.